These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 2701811

  • 1. Designs for efficient clinical trials.
    Simon R.
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A practical limit to trials needed in one-person randomized controlled experiments.
    Alemi R, Alemi F.
    Qual Manag Health Care; 2007 Jul; 16(2):130-4. PubMed ID: 17426611
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM.
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.
    Gray R, Manola J, Saxman S, Wright J, Dutcher J, Atkins M, Carducci M, See W, Sweeney C, Liu G, Stein M, Dreicer R, Wilding G, DiPaola RS.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):1966-9. PubMed ID: 16609005
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Power of 'phase 0' chronobiologic trials at different signal-to-noise ratios and sample sizes.
    Bingham C, Cornélissen G, Halberg F.
    Chronobiologia; 1993 Apr 01; 20(3-4):179-90. PubMed ID: 8131667
    [Abstract] [Full Text] [Related]

  • 16. Sequential designs for equivalence studies.
    Whitehead J.
    Stat Med; 1996 Dec 30; 15(24):2703-15. PubMed ID: 8981681
    [Abstract] [Full Text] [Related]

  • 17. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC, Stephen Coad D.
    Stat Med; 2007 Apr 30; 26(9):1937-54. PubMed ID: 16981177
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment.
    Whitehead J, Matsushita T.
    Stat Med; 2003 Mar 15; 22(5):677-87. PubMed ID: 12587099
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.